CD7 and lymphoblastic lymphoma: One recent research enrolled 60 patients with R/R T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma (T-ALL/LBL), 58 of whom received autologous CD7 CAR-T cell therapy and 2 other patients received donor-derived CD7 CAR-T cell infusion.